Thyroid dysfunction is common and treatable — but the biochemical pattern is only the starting point. The cause, urgency, and patient context determine whether and how to treat. Hypothyroidism and hyperthyroidism require fundamentally different approaches.
CLINICAL PRINTABLE
Coming Soon.
A one-page Hypothyroidism / Hyperthyroidism Management clinical reference is on the way.
1 · Recognition / Confirmation
- Primary hypothyroidism generally produces elevated TSH with low free T4 when overt; subclinical disease has elevated TSH with normal free T4.
- Primary hyperthyroidism generally produces suppressed TSH with elevated free T4 and/or T3; distinguish overt disease from subclinical patterns and nonthyroidal/medication effects.
- Review biotin/supplements, amiodarone, lithium, recent illness, pregnancy status when relevant, prior thyroid surgery/ablation, autoimmune history, and symptoms.
- Sick euthyroid syndrome (nonthyroidal illness) can suppress TSH and free T4 in critically ill patients — avoid routine thyroid testing in acute illness unless thyroid dysfunction is specifically suspected.
2 · Hypothyroidism Treatment Pathway
- Levothyroxine is standard replacement therapy for primary hypothyroidism; starting intensity depends on age, severity, cardiac disease, pregnancy, and clinical context.
- Administration consistency matters: food, calcium, iron, and several medications can impair absorption. Take on an empty stomach, 30–60 minutes before food.
- Recheck TSH after an appropriate steady-state interval (typically 6–8 weeks) following dose changes; avoid rapid serial adjustments before the new dose has equilibrated.
- Persistent abnormal TSH despite apparently adequate dosing should trigger adherence, timing, interaction, malabsorption, and diagnostic review before endless dose escalation.
3 · Hyperthyroidism Treatment Pathway
- Symptomatic adrenergic features may be treated with beta-blockade when appropriate while the cause is evaluated.
- Antithyroid drug selection and definitive therapy depend on Graves disease vs toxic nodular disease vs thyroiditis, pregnancy context, severity, adverse-effect risk, and specialist plan.
- Thyroiditis-related thyrotoxicosis is not treated the same as hormone overproduction; antithyroid drugs may not address hormone leakage.
- Educate patients receiving thionamides about serious adverse-effect warning symptoms — agranulocytosis (fever, sore throat) and hepatotoxicity require prompt evaluation.
4 · Expected Response / Failure
- Symptoms may lag behind biochemical improvement — TSH normalization precedes full symptom resolution.
- Hypothyroidism: expect TSH to normalize over weeks to months with appropriate levothyroxine dosing; symptoms improve gradually.
- Hyperthyroidism: antithyroid drugs typically normalize thyroid function over 4–8 weeks; beta-blockade provides earlier symptom relief.
- Failure to normalize TSH despite adequate therapy should prompt reassessment of adherence, absorption, diagnosis, and specialist review.
5 · Escalation
- Myxedema coma: altered consciousness, hypothermia, bradycardia, hypoventilation — IV levothyroxine, stress-dose steroids, ICU-level supportive care.
- Thyroid storm: fever, tachycardia, altered mentation, cardiovascular instability — antithyroid drugs, beta-blockade, iodine (after antithyroid drug), steroids, ICU care.
- Agranulocytosis on thionamides: stop the drug immediately, obtain CBC, urgent hematology/endocrinology consultation.
- Endocrinology referral for Graves disease, toxic nodular goiter, thyroid storm, pregnancy, or management not responding to standard approaches.
Apply It · Change One Detail
APPLY IT
A patient on levothyroxine has a persistently elevated TSH despite dose increases. Before escalating further, review: is the patient taking it consistently on an empty stomach? Are there calcium, iron, or PPI interactions? Is there malabsorption (celiac, bariatric surgery)?
CHANGE ONE DETAIL
Change one detail — the same patient has a suppressed TSH and elevated free T4 with palpitations and tremor. Now the question is the cause: Graves disease, toxic nodule, thyroiditis, or exogenous thyroid hormone. The cause determines the treatment.
Bottom Line
TSH is the most sensitive marker for thyroid dysfunction — but context matters. Sick euthyroid, medications, and assay interference can all produce misleading results.
EVIDENCE & REFERENCES
- Jonklaas J, et al. Guidelines for the Treatment of Hypothyroidism. Thyroid. 2014;24(12):1670-1751. doi:10.1089/thy.2014.0028
- Ross DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism. Thyroid. 2016;26(10):1343-1421. doi:10.1089/thy.2016.0229